For Centers

42 CFR Part 2 after the 2024 rule: what changed for treatment center marketing and intake

Published November 21, 2026 · 9 min read

The 2024 Part 2 final rule changed how substance use disorder records move between providers and payers, and it changed what happens when a program gets it wrong. It did not create a marketing exception. If your admissions team, call tracking vendor, or ad platform touches information that identifies someone as a person seeking SUD treatment, you still need a valid written consent or another specific Part 2 permission before that information leaves the program. What is new is the enforcement: penalties now follow HIPAA's civil and criminal structure, the HHS Office for Civil Rights handles complaints, and the HIPAA breach notification rules apply to Part 2 records.

HHS published the final rule in the Federal Register on February 16, 2024. It took effect April 16, 2024, and programs had until February 16, 2026 to comply. It implements Section 3221 of the CARES Act, which Congress passed in 2020 to bring Part 2 closer to HIPAA. For background on what Part 2 protects in the first place, see our plain-language explainer on 42 CFR Part 2.

What the rule changed

Most of the changes were aimed at care coordination.

None of these items mentions advertising, lead generation, or digital marketing. That silence matters. The convenience of the TPO consent stops at treatment, payment, and health care operations. Marketing is not one of those purposes, and a program that reads the TPO consent as a general license to share patient data has misread the rule.

Who counts as a patient at intake

This is the point that most often trips up admissions teams. Part 2 defines a patient as anyone who has applied for or been given diagnosis, treatment, or referral for treatment at a Part 2 program. A person who calls your admissions line, fills out an insurance verification form, or starts a chat asking about detox has, in most cases, applied for treatment. They do not have to be admitted for their information to be protected.

That has practical consequences. The caller's name, phone number, and the fact that they contacted a substance use program are all information that would identify them as a person seeking SUD care. A call recording, a CRM record created by your intake coordinator, and the transcript your call tracking platform generates are all Part 2 records once they are tied to that person.

Part 2 applies to programs that are federally assisted and hold themselves out as providing SUD diagnosis, treatment, or referral. Federal assistance is defined broadly. Medicare or Medicaid participation, a DEA registration, and federal tax-exempt status all qualify. Very few licensed treatment centers fall outside it.

Where marketing and intake data flows go wrong

The common problems come from ordinary marketing tools set up by someone thinking about conversion rates, not 42 CFR 2.13.

Tracking pixels on intake and verification pages

Analytics and advertising pixels from large platforms can send page URLs, form field contents, and device identifiers back to the platform. On a page titled "Verify your insurance for alcohol detox," the URL alone can reveal what the visitor is seeking. OCR issued a bulletin on online tracking technologies in December 2022 and revised it in March 2024. A federal district court in Texas vacated part of that guidance in June 2024, the part dealing with unauthenticated public pages. That ruling interpreted HIPAA, not Part 2, and it did nothing to change Part 2's consent requirement for records about applicants. The safest setup keeps third-party advertising pixels off any form, chat, or scheduling page where a person submits information about themselves or a family member.

Offline conversion uploads and customer lists

Ad platforms invite you to upload lists of people who converted, matched by phone or email, so the algorithm can find more people like them. For a treatment program, that list is a list of patients and applicants. Uploading it discloses to the ad platform that each person sought SUD treatment. A TPO consent does not cover it. A Part 2 compliant consent specifically for that disclosure would be required, and most programs should not do this at all.

Call tracking, answering services, and CRMs

A vendor that receives Part 2 records so it can perform a service for your program needs a qualified service organization agreement, and if you are a HIPAA covered entity, a business associate agreement as well. Many call tracking tools are built for general businesses and will not sign either. Before you route admissions calls through one, confirm the agreement exists and check what the vendor does with recordings and caller data, including whether it passes them to ad platforms.

Updates to referral sources

Interventionists, sober companions, outside marketers, and alumni coordinators often expect to hear whether a person they referred was admitted. Confirming admission is a disclosure. A referring physician who is treating the patient may fall within a TPO consent. A marketing representative or a paid referral source does not, and paying for referrals raises separate problems under the federal Eliminating Kickbacks in Recovery Act (EKRA), which we cover in our EKRA compliance guide.

Testimonials, alumni content, and fundraising

Patient stories, video testimonials, and alumni event photos identify people as former patients. Each needs a written consent that meets Part 2's requirements, and the patient can revoke it. If your program raises money, the 2024 rule requires that patients get a clear opportunity to opt out before their records are used for fundraising appeals.

What to check in your intake paperwork

Pull your current consent forms and compare them against the required elements in 42 CFR 2.31. The TPO consent can describe recipients by class, such as the patient's treating providers and health plans, which is much simpler than naming each one. It still has to state what information may be disclosed, the purpose, the patient's right to revoke, and an expiration date or event. It also needs to tell the patient that records disclosed to a HIPAA covered entity may be redisclosed under HIPAA. The consent for use in legal proceedings cannot be bundled with the others, and the counseling notes consent can only be combined with another counseling notes consent.

Your patient notice should now track the HIPAA Notice of Privacy Practices format and include the fundraising opt-out and the right to request restrictions. Staff who handle intake calls need to know that a caller is protected before admission, and that "we can't confirm whether that person is here" is the correct answer to most outside inquiries. If your HIPAA training predates 2024, it probably does not cover these points. Our compliance guide for treatment centers and the article on how HIPAA and Part 2 fit together are useful starting points for updating it.

Breach response is now a different exercise

Before the rule, a Part 2 violation was mostly a theoretical criminal exposure that rarely led to enforcement. Now an impermissible disclosure of unsecured records is presumed to be a reportable breach unless a documented risk assessment shows a low probability that the information was compromised. A misconfigured pixel that sent intake form data to an ad platform for a year could mean individual notices to every affected applicant and a report to HHS. Breaches affecting 500 or more people are posted publicly on the HHS breach portal.

Run an inventory now: every script on your website, every vendor that touches admissions data, every place a patient or applicant list is exported. For each one, write down which Part 2 permission covers it. Anything without an answer should be shut off until it has one.

Marketing that fits the rule

Programs that depend on audience matching and conversion uploads will find the 2024 rule uncomfortable. Programs that grow through referrals from clinicians, accurate public listings, and a website that answers real questions will find it barely affects their marketing. Being listed accurately in neutral resources like the Treatment Association directory requires no patient data at all, and neither does publishing honest information about your levels of care, insurance, and staff. We wrote more about that approach in marketing without per-lead fees.

If your program meets the standards we publish, you can apply for free Treatment Association verification, which is earned through review and never sold.

Frequently asked questions

Does the 2024 Part 2 rule let us use patient data for marketing under the TPO consent?
No. The single consent covers treatment, payment, and health care operations. Marketing is not one of those purposes, so disclosing patient or applicant information to an ad platform or marketing vendor still requires a separate, specific written consent that meets 42 CFR 2.31.
Is someone who calls our admissions line but never admits protected by Part 2?
Generally yes. Part 2 defines a patient as anyone who has applied for or been given diagnosis, treatment, or referral for treatment at a Part 2 program. An intake call or insurance verification request is usually an application for treatment.
When did programs have to comply with the 2024 rule?
The rule took effect April 16, 2024, and the compliance date was February 16, 2026. Programs are now expected to be operating under it.
Who enforces Part 2 now?
The HHS Office for Civil Rights takes complaints and investigates, and violations are subject to the civil money penalty tiers and criminal penalties used for HIPAA.
Do we need an agreement with our call tracking vendor?
If the vendor receives Part 2 records, such as call recordings or caller information tied to SUD treatment inquiries, it needs a qualified service organization agreement, and a business associate agreement if your program is a HIPAA covered entity. If a vendor will not sign, do not route admissions calls through it.

Related resources

Need help now?
Call or text 988 (Suicide & Crisis Lifeline), or SAMHSA's free 24/7 helpline at 1-800-662-4357. You can also search 18,215 treatment facilities.